1. Home
  2. WDC vs NTRA Comparison

WDC vs NTRA Comparison

Compare WDC & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Digital Corporation

WDC

Western Digital Corporation

HOLD

Current Price

$168.81

Market Cap

41.3B

Sector

Technology

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.52

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDC
NTRA
Founded
1970
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Electronic Components
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
41.3B
27.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
WDC
NTRA
Price
$168.81
$244.52
Analyst Decision
Buy
Strong Buy
Analyst Count
24
16
Target Price
$149.17
$227.69
AVG Volume (30 Days)
8.3M
1.7M
Earning Date
10-30-2025
11-06-2025
Dividend Yield
0.30%
N/A
EPS Growth
578.01
N/A
EPS
6.90
N/A
Revenue
$10,126,000,000.00
$2,116,676,000.00
Revenue This Year
$24.25
$32.77
Revenue Next Year
$12.58
$16.51
P/E Ratio
$23.60
N/A
Revenue Growth
75.22
38.17
52 Week Low
$28.83
$125.38
52 Week High
$178.45
$245.59

Technical Indicators

Market Signals
Indicator
WDC
NTRA
Relative Strength Index (RSI) 61.91 80.03
Support Level $151.42 $233.67
Resistance Level $169.72 $240.18
Average True Range (ATR) 9.99 7.39
MACD -0.30 0.68
Stochastic Oscillator 97.56 97.49

Price Performance

Historical Comparison
WDC
NTRA

About WDC Western Digital Corporation

Western Digital is a leading vertically integrated supplier of hard disk drives. The HDD market is a practical duopoly, with Western Digital and Seagate being the two largest players. Western Digital designs and manufactures its HDDs, with much of the manufacturing and workforce located in Asia. The primary consumers of HDDs are data centers.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: